---
title: 'Senior Manager, Accounting and SEC Reporting at Bicara Therapeutics'
canonical: 'https://feeny.ai/job/senior-manager-accounting-and-sec-reporting-bicara-therapeutics-boston-hngf1v66tht9'
type: 'job'
last_seen: '2026-09-13'
---

# Senior Manager, Accounting and SEC Reporting at Bicara Therapeutics

- **Company:** Bicara Therapeutics
- **Location:** Boston, MA
- **Employment:** full-time
- **Work type:** hybrid
- **Posted:** 2026-07-22
- **Last confirmed live:** 2026-09-13
- **Apply:** https://jobs.ashbyhq.com/bicara-therapeutics/7f3d3590-99fb-480c-8760-79a0f6eb05c2

## Job description

Position Overview Bicara Therapeutics is seeking a proactive and detail-oriented Senior Manager, Accounting and SEC Reporting, to join our growing Accounting Team. This individual will report to the Senior Director, Accounting and will be responsible for preparation of all SEC reporting documents including Form 10K and 10Q. This position will also be responsible for preparing and managing G&A accruals, for performing all activities related to company’s stock compensation expenses and for working both independently and as part of a team to support Bicara's launch compliance with Sarbanes-Oxley Act requirements. This is a hands-on position and the ability to multitask and work with others is essential.

This role is based in our Boston office and follows a hybrid schedule, with three in-office days each week.

## Responsibilities

- Leads the preparation of Form 10-Q quarterly reports, Form 10-K annual reports, financial sections of earning press releases and other current reports as needed.
- Manages external SEC financial reporting and filing process, including internal and external comments drafting of financial statements, footnotes and MD&A, completing GAAP checklists, as well as maintaining and reviewing XBRL tagging.
- Monitors the development and applicability of emerging accounting and reporting rules being deliberated by the SEC, PCAOB, or other regulations.
- Partner with the Controller and the Senior Director of Accounting on the review and assessment of complex accounting matters and new accounting standards under U.S. GAAP, ensuring timely and accurate reporting.
- Lead accounting for stock-based compensation for compliance with ASC 718, including preparation of stock-based compensation expenses journal entries.
- Prepare and post monthly journal entries and prepare monthly account reconciliation for assigned areas including G&A accrual, cash & investment, fixed assets and leases.
- Collaborate with other G&A teams including legal, IR and others as needed to ensure that relevant information is shared timely.
- Develop and maintain accounting policies and procedures.
- Identify opportunities to streamline and automate controls and reporting processes.

## Qualifications

- BS/MS in Accounting and 8 plus years of relevant experience.
- Solid understanding of US GAAP and ability to manage multiple priorities.
- Ability to research and interpret accounting guidance and draft accounting memos to support conclusions.
- Proven subject matter knowledge, demonstrated attention to detail and ability to communicate effectively with the team.
- Demonstrated strong interpersonal skills and effectiveness in working collaboratively with cross functional team members and with external partners.
- Strong team player that has a customer service approach and is solution oriented.
- Demonstrated ability and willingness to drill-in to operational details while maintaining appropriate whole-company perspective (zoom-in, zoom-out).
- Ability to work individually, within a multi-disciplinary team, as well as with external partners and vendors.
- Excitement about the mission of Bicara.
- Prior experience at a biotech, life sciences, or other high-growth technology company.
- Proficient knowledge of Excel, Word, PowerPoint.

## Preferred Qualifications

- Active CPA license.
- Prior experience working with Workiva or similar SEC reporting platform.
- Experience working with NetSuite, Prendio and [Bill.com.](http://Bill.com) Company Overview Bicara Therapeutics is a clinical-stage biotech company pioneering bifunctional antibodies for targeted tumor modulation. Founded in 2020, we've built a global team of over 100 employees headquartered in Boston, with a clear focus on advancing our lead asset, ficerafusp alfa, or FICERA - a potentially first-in-class bifunctional EGFR-directed antibody combined with a TGF-β ligand trap. Our innovative approach combines tumor-targeting with tumor modulation, where one arm localizes to the tumor while the other serves as a modulator, designed to deliver superior efficacy, improved safety, and enhanced durability directly at the tumor site. FICERA specifically addresses a key challenge in solid tumor treatment by enabling immune cell penetration into tumors, reducing fibrosis and immunosuppression while reversing TGF-β-driven resistance mechanisms - ultimately designed to drive the deep, durable responses that may translate into better outcomes and survival for patients. For more information, please visit [www.bicara.com](http://www.bicara.com). Here at Bicara, we believe in building diverse teams and cultivating a culture where all voices are included. We encourage people from all backgrounds to apply. Bicara Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.

## About Bicara Therapeutics

## Company Overview
- **One-liner**: Bicara Therapeutics is a clinical-stage biotechnology company developing first-in-class bifunctional antibodies that combine tumor-targeting with tumor microenvironment modulation, with a lead asset in head and neck squamous cell carcinoma.
- **Entity Type**: Public (NASDAQ: BCAX)
- **Headquarters**: Boston, Massachusetts, USA
- **Founded**: 2020
- **Founders**: Not publicly listed

## Core Business
- **Industry**: Biotechnology – oncology drug development
- **Target Customers**: B2B (pharma partnerships, licensing) and ultimately cancer patients and healthcare providers
- **Mission**: "Dedicated to improving the lives of people living with cancer through the development of innovative targeted therapies… bringing hope and control back into their lives." [bicara.com](https://www.bicara.com/)

## Products & Services
- **[Ficerafusp alfa (BCA101)](https://www.bicara.com/)**: First-in-class, dual-action bifunctional antibody targeting EGFR and containing a TGF-β ligand trap. Currently in Phase 1/1b clinical development for HPV-negative head and neck squamous cell carcinoma and other solid tumors. Mechanism designed to deliver an immunomodulatory payload directly to the tumor microenvironment, reduce fibrosis/immunosuppression, and enable immune cell penetration. (Biologic, clinical-stage therapeutic)

## Market Standing
- **Valuation/Market Cap**: ~$1.3 billion (as of mid-2026) [linkedin.com](https://www.linkedin.com/company/bicara-therapeutics)
- **Key Metric**: Total funding raised $825M (includes Series C $165M led by The Rise Fund and TPG, $362M from 2024 IPO, and a $150M post-IPO equity round in February 2026) [linkedin.com](https://www.linkedin.com/company/bicara-therapeutics)
- **Notable Investors/Partners**: The Rise Fund, TPG, Biocon (seed round). Additional institutional investors from IPO and follow-on offerings.
- **Growth Signals**: IPO completed September 2024; headcount grew 78.1% year-over-year (95 employees, though LinkedIn notes a slight monthly decline of -0.9%); operates across 8 countries including the UK, Italy, Germany, India, and Spain; 11 active job postings as of mid-2026. [linkedin.com](https://www.linkedin.com/company/bicara-therapeutics)

## Competitive Advantages
- **First-in-class bifunctional approach**: By combining an EGFR-targeting antibody with a TGF-β trap, BCA101 directly addresses a key solid-tumor resistance mechanism (TGF-β-driven immunosuppression and fibrosis) while localizing therapy to the tumor.
- **Potential for superior efficacy and safety**: Designed to deliver synergistic therapeutic impact at the tumor site, aiming for deep, durable responses with reduced systemic toxicity.
- **Experienced leadership**: Team with deep oncology drug development backgrounds and relationships with top cancer centers. [bicara.com/about](https://www.bicara.com/about/)

## Strategic Focus
- **Priority**: Advancing ficerafusp alfa through clinical development toward potential regulatory approvals, initially in HPV-negative head and neck squamous cell carcinoma.
- **Pipeline expansion**: Leveraging the bifunctional antibody platform (BCA101 and follow-on programs) to address multiple solid tumor types.
- **Commercial readiness**: Hiring senior roles in medical affairs, quality, regulatory, and commercial operations signals preparation for launch. [bicara.com/careers](https://www.bicara.com/careers/)

## Why Work Here
- **Culture & Mission**: A patient-first, mission-driven environment focused on developing meaningful new therapies for cancer. Company describes itself as "dynamic" with a shared passion for advancing science. [bicara.com](https://www.bicara.com/)
- **Diversity & Inclusion**: Explicitly states commitment to building diverse teams and encourages applicants from all backgrounds. [bicara.com/careers](https://www.bicara.com/careers/)
- **Growth Trajectory**: Fast-growing public company (78% headcount growth YoY) with a strong balance sheet, offering career progression opportunities.
- **Work Environment**: Headquarters in Boston with a global presence. Specific remote/hybrid policy not publicly detailed, but the company employs staff across 8 countries. Glassdoor rating of 4.0/5 on LinkedIn based on limited reviews. [linkedin.com](https://www.linkedin.com/company/bicara-therapeutics)
- **Engagement**: Active hiring across multiple senior-level roles in medical affairs, regulatory, quality, IT, and clinical operations, indicating a ramp-up toward commercialization. [bicara.com/careers](https://www.bicara.com/careers/)

## Sources
1. [bicara.com](https://www.bicara.com/) – Company home page, product, mission
2. [bicara.com/about](https://www.bicara.com/about/) – Leadership team, technology description
3. [bicara.com/careers](https://www.bicara.com/careers/) – Open positions, culture, diversity statement
4. [linkedin.com/company/bicara-therapeutics](https://www.linkedin.com/company/bicara-therapeutics) – Headcount, financials, stock info, employee reviews, talent sources
5. [massbio.org/members/bicara-therapeutics](https://www.massbio.org/members/bicara-therapeutics/) – Membership description, pipeline summary

## Other roles at Bicara Therapeutics

- [Senior Manager, GxP Audit Program Lead](https://feeny.ai/job/senior-manager-gxp-audit-program-lead-bicara-therapeutics-boston-z2743dyfw8v5) — Boston, MA
- [Director, Biostatistics](https://feeny.ai/job/director-biostatistics-bicara-therapeutics-boston-8acrty1k88h7) — Boston, MA
- [Director, Marketing Operations](https://feeny.ai/job/director-marketing-operations-bicara-therapeutics-boston-308n8g5t9f73) — Boston, MA
- [Senior Medical Science Liaison - West (CA, WA)](https://feeny.ai/job/senior-medical-science-liaison-west-ca-wa-bicara-therapeutics-united-states-tv5xs4prg9y2) — United States
- [Associate Director, Financial Planning & Analysis (Development Finance Business Partner)](https://feeny.ai/job/associate-director-financial-planning-analysis-development-finance-business-nt8nz0xbxns1) — Boston, MA
- [Associate Director, Global Scientific Communications](https://feeny.ai/job/associate-director-global-scientific-communications-bicara-therapeutics-boston-b20sj17zmqbw) — Boston, MA
- [Sr. Quality Specialist, GxP Document Control](https://feeny.ai/job/sr-quality-specialist-gxp-document-control-bicara-therapeutics-boston-pmtejzsn39sj) — Boston, MA
- [Senior Clinical Trial Manager](https://feeny.ai/job/senior-clinical-trial-manager-bicara-therapeutics-boston-07s96d5xygx4) — Boston, MA
- [Associate Director, Project Management (Clinical Operations)](https://feeny.ai/job/associate-director-project-management-clinical-operations-bicara-therapeutics-jc50anna3jrm) — United States
- [Senior Director, Regulatory Affairs](https://feeny.ai/job/senior-director-regulatory-affairs-bicara-therapeutics-boston-t7b77r839mdy) — Boston, MA